Xkelet: One Technology, Many Markets

On a particularly hot and humid day in London, Emmanuel Meyer arrived home after a full morning in the hospital with his daughter. She had broken her arm in a bicycle accident and was supposed to spend two months in a cast. This was not the summer they had been expecting, and Emmanuel was wondering about the potential drawbacks of a full cast. Just days later, as he was surfing the net, Emmanuel stumbled across the Xkelet website. Could this be a solution? At first sight, this cutting-edge Spanish startup seemed like just another orthopedic company producing 3D printed immobilization devices. But the technology behind the product was much more sophisticated. This artificial intelligence (AI) and machine learning company had developed a software capable of scanning any part of the body, taking out anthropometric data, and creating the orthosis via 3D printing in less than two hours. Hopeful, Emmanuel caught a flight to Girona, a city 80km north of Barcelona, where he met Jordi Tura Ceide, CEO, and Pedro V. Hernandez, CMO. Some months later, after seeing the excellent results on his daughter's arm, Emmanuel became a company shareholder. Within five years of founding, Xkelet had achieved visibility and results in the field of orthopedics and had a disruptive technology that could be implemented in other sectors. Should Tura and Hernández continue developing their core business or focus on entering new markets? What might be the best strategy to access these new markets and how should financing the operation be approached? Potential partners might be needed, but where could they be found?